540 related articles for article (PubMed ID: 10048117)
21. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
[TBL] [Abstract][Full Text] [Related]
23. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
24. Identification and treatment of APS renal involvement.
Tektonidou MG
Lupus; 2014 Oct; 23(12):1276-8. PubMed ID: 25228725
[TBL] [Abstract][Full Text] [Related]
25. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
[TBL] [Abstract][Full Text] [Related]
26. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus.
Broder A; Putterman C
J Rheumatol; 2013 Jan; 40(1):30-3. PubMed ID: 22859353
[TBL] [Abstract][Full Text] [Related]
27. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
[TBL] [Abstract][Full Text] [Related]
28. Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
Garcia L; Velloso MS; Martire MV; Savy F; Arizpe F; Garcia N; Testi A; Pena C; Costi AC; Isnardi C; Capelusnik D; Mazza S; Curi YS; Collado V; Rodriguez MF; Scarafia S; Pisoni C; de la Torre M; Seewald A; Riva ME; Garcia M
Lupus; 2020 Dec; 29(14):1866-1872. PubMed ID: 33028177
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis.
Moroni G; Ventura D; Riva P; Panzeri P; Quaglini S; Banfi G; Simonini P; Bader R; Meroni PL; Ponticelli C
Am J Kidney Dis; 2004 Jan; 43(1):28-36. PubMed ID: 14712424
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes.
Yap DYH; Thong KM; Yung S; Tang C; Ma BMY; Chan TM
Lupus; 2019 Oct; 28(12):1460-1467. PubMed ID: 31594451
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM
Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
[TBL] [Abstract][Full Text] [Related]
33. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
[TBL] [Abstract][Full Text] [Related]
34. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid Syndrome and the Kidney.
Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
[TBL] [Abstract][Full Text] [Related]
36. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
Kotzen ES; Roy S; Jain K
Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study.
Qi W; Zhao J; Huang C; Jiang N; Li J; Wu C; Zhang S; Hu C; Xu D; Wang Q; Li M; Tian X; Zhao Y; Zeng X
Arthritis Res Ther; 2022 Jun; 24(1):140. PubMed ID: 35690831
[TBL] [Abstract][Full Text] [Related]
39. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
40. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
